Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease
F1000Research · 2025
DOI: 10.12688/f1000research.145391.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2025. Verfasst von Suggala Ramya Shri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Molecular Dynamics Simulation, Glycogen Synthase Kinase 3 beta, Molecular Docking Simulation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.
Themen: Simulation in der Pflegeausbildung, Demenz
Abstract (Originalsprache)
Background
The discovery of an ideal and effective therapy is urgently required for the treatment of Alzheimer’s disease (AD). The main pathological hallmarks of Alzheimer’s disease that appear before the clinical symptoms are neurofibrillary tangles, amyloid plaques, brain inflammation, and neuronal atrophy throughout the cerebral cortex and hippocampus. GSK-3β (Glycogen Synthase Kinase-3β) is regarded as the most important and promising target for therapeutic use because GSK-3β expression levels increase with age and are the most abundant and hyperactive in the brains of patients with AD. GSK-3β activation or upregulation can contribute to neurodegeneration by promoting amyloid beta (Aβ) production and tau hyperphosphorylation. Whereas the underlying mechanism for abnormal production of GSK-3β in AD brains remains unclear.
Methods
Maestro was used, which is Schrodinger, for our computational simulation studies. In the present work, different modules that were used in previous studies with a little modification, the modules such as Protein Preparation with the help of Protein Preparation Wizard, Ligand Preparation with the help of LigPrep, for ADME (Absorption, Distribution, Metabolism and Excretion) prediction Qikprop was used, for docking studies Glide module was used, Binding energy prediction the Prime was used and Molecular dynamic simulation (MDs) studies done using Desmond.
Results
Our focus is mainly on an in-silico approach, focusing on library generation; first draw an IMID2 (imidazo [1,5-a]pyridine-3-carboxamide) scaffold structure at Enamine and subjected it to a substructure search to target the receptor grid region (ATP-competitive site) of 6Y9R. They were then subjected to various screening processes. Finally, nine compounds were subjected to MDs studies.
Conclusions
Nine compounds showed good results with the most stable interactions. Among all the MD studies, the compound (Z3336252116) has shown good interaction and a good docking score. Further experiments and studies are required to confirm these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
ORCID-Profile: Yogendra Nayak, Sreedhara Ranganath Pai
Förderung
- Indian Council of Medical Research
Zitieren
APA
Shri, S. R., Nayak, Y., & Ranganath Pai, S. (2025). Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease. F1000Research. https://doi.org/10.12688/f1000research.145391.3
Vancouver
Shri SR, Nayak Y, Ranganath Pai S. Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease. F1000Research. 2025. doi:10.12688/f1000research.145391.3
BibTeX
@article{Shri2025,
author = {Shri, Suggala Ramya and Nayak, Yogendra and Ranganath Pai, Sreedhara},
title = {Molecular docking studies and molecular dynamic simulation analysis: To identify novel ATP-competitive inhibition of Glycogen synthase kinase-3β for Alzheimer’s disease},
journal = {F1000Research},
year = {2025},
doi = {10.12688/f1000research.145391.3}
}
EUVIMED